Rezolute (RZLT) Accumulated Expenses (2011 - 2026)
Rezolute (RZLT) reported Accumulated Expenses of $1.0 million for Q1 2026, down 0.96% on a YoY basis from $1.0 million in Q1 2025, and down 32.51% sequentially from $1.5 million in Q4 2025.
Rezolute (RZLT) Accumulated Expenses (2011 - 2026) Analysis & Trends
Rezolute (RZLT) has 16 years of Accumulated Expenses data on file, last reported at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses fell 0.96% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (down 0.96% YoY), and the FY2025 full-year result was $2.3 million, up 25.22% from the prior year.
- Accumulated Expenses declined to $1.0 million in Q1 2026, from $1.5 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $4.0 million in Q4 2024 to a low of $450000.0 in Q1 2022.
- A 5-year average of $1.9 million and a median of $1.7 million in 2023 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses soared 150.0% in 2022 and slumped 61.5% in 2025, its largest moves.
- Tracing RZLT's Accumulated Expenses over 5 years: stood at $2.2 million in 2022, then gained by 11.15% to $2.5 million in 2023, then surged by 60.25% to $4.0 million in 2024, then tumbled by 61.5% to $1.5 million in 2025, then tumbled by 32.51% to $1.0 million in 2026.
- Business Quant data shows RZLT's Accumulated Expenses at $1.0 million in Q1 2026, $1.5 million in Q4 2025, and $3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 3.32 Mn |
| Jun 30, 2025 | 2.27 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 3.98 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Mar 31, 2024 | 879,000.00 |
| Dec 31, 2023 | 2.48 Mn |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 883,000.00 |
| Dec 31, 2022 | 2.23 Mn |
| Mar 31, 2022 | 450,000.00 |
| Dec 31, 2021 | 1.47 Mn |
| Jun 30, 2021 | 77,000.00 |
| Mar 31, 2021 | 180,000.00 |
| Dec 31, 2020 | 1.26 Mn |
| Sep 30, 2020 | 79,000.00 |
| Jun 30, 2020 | 120,000.00 |